The prognostic and predictive value of homologous recombination deficiency status in patients with advanced stage epithelial ovarian carcinoma after first-line platinum-based chemotherapy.

Front Oncol · 2024 · PMC11194312 · PMID 38915363

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

a strong trendp= 0.052so close (0.05 < p ≤ 0.1)

In addition, PFI was 32.7 months (95% CI 13.8-NA) in the all genetic mutation group, and 15.9 months (95% CI 8.3-34.1) in the HRP group, showing a strong trend toward statistical difference (p= 0.052).

also in 868 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.